New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Oncolytics Biotech Inc.
ONCY
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

59M

Biotechnology

Next Earning date - 06 Mar 2025

59M

Biotechnology

Next Earning date - 06 Mar 2025

0.77USD

Shape-0.00 ( -0.63%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

11
favorite-chart

Volume Buzz

-79%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

50%

Quote Panel

Shape
Updated February 15, 2025
1W 0.27 % 1M -8.50 % 3M -22.89 % 1Y -33.86 %

Key Metrics

Shape
  • Market Cap

    59.13M


  • Shares Outstanding

    77.07M


  • Share in Float

    75.69M


  • Dividende

    0


  • Earning Date

    06 Mar 2025


  • Price Target

    0.7672


  • Average Volume

    1.24M


  • Beta

    1.506


  • Range

    0.67-1.53


  • Industry

    Biotechnology


  • Website

    https://www.oncolyticsbiotech.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

ONCY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1M

ShapeNaN%

2025-Revenue

$0.48

Shape-271%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Raymond James

initialise

Previous: Not converted

2024-04-04

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.10
vs -0.11

Q1.23

arrow
arrow

N/A

-0.07
vs -0.09

Q2.23

arrow
arrow

N/A

-0.09
vs -0.07

Q3.23

arrow
arrow

N/A

-0.10
vs -0.06

Q4.23

arrow
arrow

N/A

-0.04
vs -0.10

Q1.24

arrow
arrow

N/A

-0.07
vs -0.07

Q2.24

arrow
arrow

N/A

-0.07
vs -0.09

Q3.24

arrow
arrow

N/A

-0.09
vs -0.10

Q4.24

arrow
arrow

N/A

-0.12
vs -0.04

Q1.25

arrow
arrow

N/A

-0.12
vs -0.07

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

NA

1.6M  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-32%

-0.32
vs -0.16

Q1.23

arrow
arrow

-24%

-0.24
vs -0.32

Q2.23

arrow
arrow

-33%

-0.33
vs -0.24

Q3.23

arrow
arrow

-34%

-0.34
vs -0.33

Q4.23

arrow
arrow

-14%

-0.14
vs -0.34

Q1.24

arrow
arrow

-30%

-0.30
vs -0.14

Q2.24

arrow
arrow

-40%

-0.40
vs -0.30

Q3.24

arrow
arrow

-105%

-1.05
vs -0.40

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

32

32
vs 35

-9%

Q2.23

arrow
arrow

30

30
vs 32

-6%

Q3.23

arrow
arrow

33

33
vs 30

10%

Q4.23

arrow
arrow

43

43
vs 33

30%

Q1.24

arrow
arrow

35

35
vs 43

-19%

Q2.24

arrow
arrow

41

41
vs 35

17%

Q3.24

arrow
arrow

42

42
vs 41

2%

Q4.24

arrow
arrow

27

27
vs 42

-36%

Earnings Growth

Latest News